COVID-19: Impact of and on Diabetes Jonathan SchofieldLalantha LeelarathnaHood Thabit Review Open access 06 June 2020 Pages: 1429 - 1435
Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review Susan RobinsonKristina S. BoyeTessa Kennedy-Martin Review Open access 10 June 2020 Pages: 1437 - 1466
Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease Cristian GujaJuan P. FríasSerge A. Jabbour Original Research Open access 18 April 2020 Pages: 1467 - 1480
A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes Mike BaxterYukiko MorimotoHiroshi Maegawa Original Research Open access 22 May 2020 Pages: 1481 - 1496
Nationwide Survey on Actual Interventions for Type 2 Diabetes by Japanese Practitioners (NSAID Study-1): Glycemic, Weight, and Blood Pressure Management Keiko AraiTetsuo NishikawaHisao Mori Original Research Open access 22 May 2020 Pages: 1497 - 1511
Chronic Medication Burden and Complexity for US Patients with Type 2 Diabetes Treated with Glucose-Lowering Agents Kristina S. BoyeReema ModyHiren Patel Original Research Open access 23 May 2020 Pages: 1513 - 1525
Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and Race Byron J. HoogwerfMichele MacKenziePranav Gandhi Original Research Open access 27 May 2020 Pages: 1527 - 1536
Disease Burden and Healthcare Costs for T2D Patients With and Without Established Cardiovascular Disease in Sweden: A Retrospective Cohort Study Lars BernfortMagnus HusbergLars-Åke Levin Original Research Open access 28 May 2020 Pages: 1537 - 1549
Assessing Diabetes Distress and Sleep Quality in Young Adults with Type 1 Diabetes Using FreeStyle Libre: A Prospective Cohort Study Ayman A. Al HayekMohamed A. Al Dawish Original Research Open access 04 June 2020 Pages: 1551 - 1562
Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study Naoto KatakamiTomoya MitaJ-DISCOVER Study Group Original Research Open access 05 June 2020 Pages: 1563 - 1578
Glycemic Control Among Patients Newly Prescribed IDegLira Across Prior Therapy Group in US Real-World Practice Leonard E. EgedeAlina BogdanovLee Kallenbach Original Research Open access 06 June 2020 Pages: 1579 - 1589
Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study Jeffrey G. SuicoUlrike HövelmannLeona Plum-Mörschel Original Research Open access 08 June 2020 Pages: 1591 - 1603
Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends Antonio Carlo BossiFranco ForloniPaolo Luigi Colombelli Letter Open access 23 May 2020 Pages: 1605 - 1606
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design Tadej BattelinoZsolt BosnyakRichard Bergenstal Correction Open access 02 May 2020 Pages: 1607 - 1608